Outsee
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $6.1M
Investors
- 4
About Outsee
Based in the UK, Outsee Limited operates as a provider of advanced genomic analysis solutions, utilizing predictive AI technology to enhance patient diagnosis and stratification. Founded in 2023, Outsee Limited is headquartered in Cambridge, UK. The company specializes in predictive genomic analysis, leveraging its innovative platform for enhanced healthcare solutions. Outsee's primary product offering is Nomaly, a predictive AI engine designed for genomic analysis. Unlike traditional methods that rely on known genetic associations, Nomaly predicts disease and phenotype directly from a single genome, leveraging fundamental principles of molecular and cell biology. By uncovering the biological mechanisms that drive and modulate disease, Nomaly enables healthcare providers to more accurately identify and categorize patients, particularly in complex genetic scenarios involving multi-variant effects and mechanistically cooperative interactions. This technology addresses significant challenges in genomic analysis by providing insights that conventional association-based methods struggle to deliver, especially in diverse patient populations. OutSee's solutions cater to a range of clients, including healthcare institutions and research organizations in North America, Europe, and Asia, enhancing their capabilities in precision medicine and patient stratification. OutSee's revenue model is centered around B2B transactions, primarily involving partnerships with healthcare providers, research institutions, and biotechnology firms. The company engages clients through subscription-based access to its Nomaly platform, allowing users to integrate the predictive capabilities into their genomic research and clinical workflows. These partnerships facilitate a steady stream of revenue as clients utilize Nomaly's technology to enhance their genomic analyses and patient care strategies. Specific pricing plans for Nomaly's offerings are structured to accommodate the varying needs of clients, ensuring scalability and accessibility for both large healthcare systems and smaller research entities.
Who invested in Outsee
4 investors across 2 rounds
See all investors in Outsee
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Outsee
Who invested in Outsee?
Outsee has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Outsee raised?
Outsee has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Outsee last raise money?
Outsee's most recent round on record is a Seed, in Jan 2026.
What does Outsee do?
Based in the UK, Outsee Limited operates as a provider of advanced genomic analysis solutions, utilizing predictive AI technology to enhance patient diagnosis and stratification.
Where is Outsee headquartered?
Outsee is headquartered in Cambridge, UK.
Which VCs invest in companies like Outsee?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Outsee's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Outsee? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.